Not all Java frameworks matter in 2026. Focus needs to be on the ones companies actually use in real projects.Choosing the ...

Most Android projects don’t fail because of bad developers. They fail because of bad technology decisions. If your mobile app development is taking too long,...Read More The post Kotlin vs Java in ...

The current OpenJDK 26 is strategically important and not only brings exciting innovations but also eliminates legacy issues ...

The most widely adopted computer language in history, COBOL is now causing a host of problems. It's also dangerously ...

In pet genetics, cancer research, and beyond, Charlie Lieu, MBA ’05, SM ’05, has spent her career harnessing massive data sets to make the world better for everyone. A photogenic green-eyed Russian ...

Multiple reports show the data centers used to store, train and operate AI models use significant amounts of energy and water, with a rippling impact on the environment and public health. According to ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Driven by the artificial intelligence frenzy, Microsoft is internally projecting that water use at its data centers will more than double by 2030 from 2020, including in places that face shortages.

Jan 13 (Reuters) - Microsoft (MSFT.O), opens new tab on Tuesday unveiled an initiative to curb water usage at its U.S. data centers and limit the impact on the general population from any potential ...

If you’re going online to buy some last-minute gifts this holiday season, there’s a chance the price you pay will be influenced by what’s known as “surveillance pricing.” Some retailers are using ...

Medicare enrollees in Texas will soon be required to get prior authorization for certain medical services – and artificial intelligence will play a central role in those decisions. Beginning Jan. 1, a ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...